News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Florian Scotté: Thanks to our partners for the 2024 MASCC-AFSOS-ISOO meeting
Photo taken from Florian Scotté/LinkedIn
Jul 3, 2024, 10:28

Florian Scotté: Thanks to our partners for the 2024 MASCC-AFSOS-ISOO meeting

Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on LinkedIn:

“Big Thanks to our partners for the 2024 MASCC-AFSOS-ISOO meeting. Your support made a great international meeting possible.”

Florian Scotté

Source: Florian Scotté/LinkedIn

2024 MASCC-AFSOS-ISOO cancer Florian Scotte Gustave Roussy Interdisciplinary Patient Pathway Organization Department (DIOPP) MASCC MASCC24 OncoDaily Oncology
Blog
Jul 5, 2024, 17:50
First-of-its-kind PhD program in cancer engineering - MSKCC
Blog
Jul 5, 2024, 17:27
Julie Ross shares the story of her career journey with OncoDaily - Advanced Clinical
Insight
Jul 5, 2024, 16:59
Pat Price: As we approach the general election, cancer must be a top priority for our new Government
Blog
Jul 5, 2024, 16:32
July edition of the IAPC's newsletter
Blog
Jul 5, 2024, 16:31
Fumiko Ladd Chino: I strongly support Dr Neha Vapiwala for President at ASTRO
Insight
Jul 5, 2024, 16:30
CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity
Blog
Jul 5, 2024, 16:21
Latest episodes from the Precision Medicine podcast
Insight
Jul 5, 2024, 16:12
Sunscreen Is Your Best Friend This Summer - Sylvester Cancer Experts
Drugs
Jul 5, 2024, 15:53
Gevorg Tamamyan: Waiting too see promising bot/bal results from our lung cancer trial
Insight
Jul 5, 2024, 15:41
Development of an EORTC QoL module for patients with advanced melanoma
Blog
Jul 5, 2024, 15:32
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Drugs
Jul 5, 2024, 15:03
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours